These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8894575)

  • 1. Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources.
    Riegel P; Ruimy R; Christen R; Monteil H
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):657-62. PubMed ID: 8894575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility.
    Lagrou K; Verhaegen J; Janssens M; Wauters G; Verbist L
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):7-15. PubMed ID: 9488824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coryneform bacteria isolated from blood cultures and their antibiotic susceptibilities.
    Balci I; Ekşi F; Bayram A
    J Int Med Res; 2002; 30(4):422-7. PubMed ID: 12235925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the applicability of amplified rDNA-restriction analysis (ARDRA) to identification of species of the genus Corynebacterium.
    Vaneechoutte M; Riegel P; de Briel D; Monteil H; Verschraegen G; De Rouck A; Claeys G
    Res Microbiol; 1995 Oct; 146(8):633-41. PubMed ID: 8584787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
    Chudnicka A; Kozioł-Montewka M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):385-91. PubMed ID: 15315020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of coryneform bacteria from blood cultures of patients at a University Hospital in Saudi Arabia.
    Babay HA; Kambal AM
    Saudi Med J; 2004 Aug; 25(8):1073-9. PubMed ID: 15322601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of Biofilm Formation, Anti-Quorum Sensing Activity and Antimicrobial Resistance in Corynebacterium Species Isolated from Clinical Samples].
    Keskin BH; Şahin İ; Kahraman G; Duran PK; Dülger G; Durmuş MA; Ceylan AN; Çalışkan E; Öksüz Ş
    Mikrobiyol Bul; 2024 Jul; 58(3):239-258. PubMed ID: 39046207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.
    Conejo Mdel C; Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1403-6. PubMed ID: 12654678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corynebacterium species causing breast abscesses among patients attending a tertiary care hospital in Chennai, South India.
    Poojary I; Kurian A; V A J; Devapriya J D; M A T
    Infect Dis (Lond); 2017 Jul; 49(7):528-531. PubMed ID: 28264610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
    Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
    Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of macrolide resistance mechanisms in clinical isolates of Corynebacterium species.
    Ortiz-Pérez A; Martín-de-Hijas NZ; Esteban J; Fernández-Natal MI; García-Cía JI; Fernández-Roblas R
    Microb Drug Resist; 2010 Dec; 16(4):273-7. PubMed ID: 20624090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.
    Sánchez Hernández J; Mora Peris B; Yagüe Guirao G; Gutiérrez Zufiaurre N; Muñoz Bellido JL; Segovia Hernández M; García Rodríguez JA
    Int J Antimicrob Agents; 2003 Nov; 22(5):492-6. PubMed ID: 14602367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of new quinolones against clinical isolates of Corynebacterium species].
    Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
    Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of clinical isolates of nondiphtherial Corynebacterium species and their antibiotic susceptibility patterns.
    Williams DY; Selepak ST; Gill VJ
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):23-8. PubMed ID: 8359002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G
    Antimicrob Agents Chemother; 1998 May; 42(5):1028-33. PubMed ID: 9593121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.
    Soriano F; Zapardiel J; Nieto E
    Antimicrob Agents Chemother; 1995 Jan; 39(1):208-14. PubMed ID: 7695308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenes.
    Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():27-32. PubMed ID: 10404334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the frequency of allocation of Corynebacteria non-diphtheria from patients with inflammatory diseases of the respiratory tract.].
    Kharseeva GG; Mangutov EO; But OM; Chepusova AV; Alutina EL
    Klin Lab Diagn; 2019; 64(7):430-434. PubMed ID: 31408596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.
    Martínez-Martínez L; Joyanes P; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2390-2. PubMed ID: 11451706
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Neemuchwala A; Soares D; Ravirajan V; Marchand-Austin A; Kus JV; Patel SN
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.